**CONFORMED**
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
X QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended November 30, 1994
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the Transition period from to
Commission File Number 0-3997
GERIATRIC & MEDICAL COMPANIES, INC.
(Exact name of registrant as specified in the charter)
Delaware 23-1713341
(State or other jurisdiction (IRS Employer Identification
of incorporation or organization) Number)
5601 Chestnut Street, Philadelphia, Pennsylvania 19139
(Address of principal executive offices) (zip code)
(215) 476-2250
Registrant's telephone number, including area code
N/A
Former name, former address and former fiscal year,
if changed since last report
Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements
for the past 90 days.
Yes X No
Indicate the number of shares outstanding of each of the issuer's
classes of common stock, as of the latest practicable date.
On January 10, 1995, there were 15,237,348 shares of common stock,
$.10 par value, outstanding.
GERIATRIC & MEDICAL COMPANIES,
INC. AND SUBSIDIARIES
INDEX
Part I Financial Information Page
Item 1 Financial Statements
Consolidated Balance Sheets ---
November 30, 1994 (unaudited)
and May 31, 1994 3
Consolidated Statements of
Operations (unaudited) ---
Three months and six months ended
November 30, 1994 and November 30, 1993 4
Consolidated Statements of
Cash Flows (unaudited) ---
Six months ended November 30, 1994
and November 30, 1993 5
Notes to Consolidated Financial Statements 6-8
Item 2 Management's Discussion and Analysis of Results of
Operations and Financial Condition 9-12
Part II Other Information
Item 6 Exhibits and Reports on Form 8-K 13
Signature 14
Exhibit 27 Article 5 - Financial Data Schedule 15
2
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
</LEGEND>
<MULTIPLIER> 1<F2>
<S> <C>
<PERIOD-TYPE> QTR - 2 <F3>
<PERIOD-START>
<PERIOD-END> NOV-30-1994
<CASH> 413,000<F4>
<SECURITIES> 0
<RECEIVABLES> 48,895,000
<ALLOWANCES> 10,731,000
<INVENTORY> 3,751,000
<CURRENT-ASSETS> 48,775,000
<PP&E> 144,252,000
<DEPRECIATION> 57,210,000
<TOTAL-ASSETS> 164,974,000
<CURRENT-LIABILITIES> 28,256,000
<BONDS> 0
<COMMON> 1,522,000
0
0
<OTHER-SE> 10,794,000
<TOTAL-LIABILITY-AND-EQUITY> 164,974,000
<SALES> 93,757,000
<TOTAL-REVENUES> 93,757,000
<CGS> 0
<TOTAL-COSTS> 82,068,000
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 4,119,000
<INTEREST-EXPENSE> 5,368,000
<INCOME-PRETAX> 2,202,000
<INCOME-TAX> 437,000
<INCOME-CONTINUING> 1,765,000
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 1,765,000
<EPS-PRIMARY> .12<F5>
<EPS-DILUTED> 0<F5>
<FN>
<F1>
</TABLE>
